SurModics, Inc. (SRDX)
-NasdaqGS 26.41 
0.05(0.19%) May 17, 4:00PM EDT
| Prev Close: | 26.36 |
|---|
| Open: | 26.40 |
|---|
| Bid: | 19.04 x 100 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 29.08 |
|---|
| Beta: | 1.29 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 26.34 - 26.68 |
|---|
| 52wk Range: | 13.53 - 27.98 |
|---|
| Volume: | 45,712 |
|---|
| Avg Vol (3m): | 83,079 |
|---|
| Market Cap: | 382.94M |
|---|
| P/E (ttm): | 29.77 |
|---|
| EPS (ttm): | 0.89 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- SURMODICS INC FinancialsEDGAR Online Financials(Fri, May 17)
- 1 Reason SurModics May Be Headed for a Slowdownat Motley Fool(Thu, May 16)
- Earnings Volatility Drives These Stocks in a New Directionat Wall St. Cheat Sheet(Sun, May 12)
- SURMODICS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 10)
- SurModics CEO Discuses Q2 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 8)
- Earnings Miss at SurModicsZacks(Wed, May 8)
- SurModics Earnings: Everything You Must Know Nowat Wall St. Cheat Sheet(Tue, May 7)
- SurModics, Inc. Earnings Call scheduled for 5:00 pm ET todayCCBN(Tue, May 7)
- SurModics Reports Second Quarter Fiscal 2013 ResultsBusiness Wire(Tue, May 7)
- SURMODICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Tue, May 7)
- Q2 2013 SurModics, Inc. Earnings Release - After Market CloseCCBN(Tue, May 7)
- SurModics to Webcast Second Quarter 2013 Earnings Conference Call on May 7Business Wire(Tue, Apr 30)
- What SurModics's Earnings Headlines Didn't Tell Youat Motley Fool(Fri, Mar 22)
- Steven Quay, CEO of Atossa Genetics, Inc. (ATOS), Interviews with The Wall Street TranscriptWall Street Transcript(Fri, Mar 15)
- See How SurModics Ranks Among Analysts' Top Picks With Strong Buyback Activityat Forbes(Tue, Mar 5)
Key Statistics
| Forward P/E (1 yr): | 26.95 |
|---|
| P/S (ttm): | 6.91 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Sep-13)
: | 0.94 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.22 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 1.87 |
|---|
Business Summary
SurModics, Inc. provides drug delivery and surface modification technologies to the healthcare industry. The company offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices,...
View More